This study investigates pancreatic cancer. It uses liquid biopsy samples to explore ways of early detection.
The study evaluates the effectiveness of a noninvasive test that uses a machine learning algorithm to distinguish between cancerous and non-cancerous conditions.
- Who can participate: Participants aged 40 to 75 with pancreatic cancer or non-malignant pancreatic disease can join.
- Study details: Participants will provide blood samples for analysis.